Neurotez is a private company focusing on the discovery and development of safe and efficacious drugs for CNS disorders.

We have used biochemical, molecular & cell biology and in vivo models to screen, identify and characterize suitable candidate biopharmaceuticals targeting major Central Nervous System disorders with unmet medical need. Dementia is the clinical expression of a multitude of pathological aberrations in the Central nervous System (CNS). The most common pathological substrate in demented elderly is Alzheimer's disease. This CNS disorder is affecting more than 5 million Americans, and 18 million pa...

We have used biochemical, molecular & cell biology and in vivo models to screen, identify and characterize suitable candidate biopharmaceuticals targeting major Central Nervous System disorders with unmet medical need. Dementia is the clinical expression of a multitude of pathological aberrations in the Central nervous System (CNS). The most common pathological substrate in demented elderly is Alzheimer's disease. This CNS disorder is affecting more than 5 million Americans, and 18 million patients worldwide. Neurotez is focused in the identification and characterization of factors relevant to obesity and/or the metabolic syndrome that modulate brain aging or the conversion of normal brain aging to that hampered with AD.